BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

94 related articles for article (PubMed ID: 7768090)

  • 21. Antimicrobial treatment of hospital-acquired pneumonia.
    Fagon JY; Chastre J
    Clin Chest Med; 2005 Mar; 26(1):97-104. PubMed ID: 15802171
    [TBL] [Abstract][Full Text] [Related]  

  • 22. [Ventilator-associated pneumonia; controversies with respect to diagnosis, pathogenesis, therapy and prevention].
    Bonten MJ; Bergmans DC; Hoepelman IM; Stobberingh EE
    Ned Tijdschr Geneeskd; 1999 Apr; 143(14):726-30. PubMed ID: 10347627
    [TBL] [Abstract][Full Text] [Related]  

  • 23. A practical application of practice-based learning: development of an algorithm for empiric antibiotic coverage in ventilator-associated pneumonia.
    Miller PR; Partrick MS; Hoth JJ; Meredith JW; Chang MC
    J Trauma; 2006 Apr; 60(4):725-9; discussion 729-31. PubMed ID: 16612290
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Novel and innovative strategies to treat ventilator-associated pneumonia: optimizing the duration of therapy and nebulizing antimicrobial agents.
    Goldstein I; Chastre J; Rouby JJ
    Semin Respir Crit Care Med; 2006 Feb; 27(1):82-91. PubMed ID: 16508884
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Reduction in inadequate empiric antibiotic therapy for ventilator-associated pneumonia: impact of a unit-specific treatment pathway.
    Magnotti LJ; Schroeppel TJ; Fabian TC; Clement LP; Swanson JM; Fischer PE; Bee TK; Maish GO; Minard G; Zarzaur BL; Croce MA
    Am Surg; 2008 Jun; 74(6):516-22; discussion 522-3. PubMed ID: 18556994
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Does bronchoalveolar lavage enhance our ability to treat ventilator-associated pneumonia in a trauma-burn intensive care unit?
    Wahl WL; Franklin GA; Brandt MM; Sturm L; Ahrns KS; Hemmila MR; Arbabi S
    J Trauma; 2003 Apr; 54(4):633-8; discussion 638-9. PubMed ID: 12707523
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Ventilator-associated pneumonia and multiresistant bacteria].
    Heininger A; Unertl K
    Anasthesiol Intensivmed Notfallmed Schmerzther; 2007 Feb; 42(2):122-9. PubMed ID: 17309020
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Ventilator-associated pneumonia: gearing towards shorter-course therapy.
    Chua Tde J; File TM
    Curr Opin Infect Dis; 2006 Apr; 19(2):185-8. PubMed ID: 16514344
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Ventilator-associated pneumonia in a newborn intensive care unit.
    Petdachai W
    Southeast Asian J Trop Med Public Health; 2004 Sep; 35(3):724-9. PubMed ID: 15689095
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Inadequate treatment of ventilator-associated pneumonia: risk factors and impact on outcomes.
    Teixeira PJ; Seligman R; Hertz FT; Cruz DB; Fachel JM
    J Hosp Infect; 2007 Apr; 65(4):361-7. PubMed ID: 17350721
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Therapy for ventilator-associated pneumonia: what works, what doesn't.
    Hijazi M; Al-Ansari M
    Respir Care Clin N Am; 2004 Sep; 10(3):341-58, vi. PubMed ID: 15458732
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Optimizing antibiotic treatment for ventilator-associated pneumonia.
    Micek ST; Heuring TJ; Hollands JM; Shah RA; Kollef MH
    Pharmacotherapy; 2006 Feb; 26(2):204-13. PubMed ID: 16466325
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Impact of superinfection on hospital length of stay and costs in patients with ventilator-associated pneumonia.
    Eagye KJ; Nicolau DP; Kuti JL
    Semin Respir Crit Care Med; 2009 Feb; 30(1):116-23. PubMed ID: 19199193
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Effects of empiric antibiotic administration for suspected pneumonia on subsequent opportunistic pulmonary infections.
    Koontz CS; Chang MC; Meredith JW
    Am Surg; 2000 Dec; 66(12):1110-4; discussion 1114-5. PubMed ID: 11149581
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Resolution of ventilator-associated pneumonia: prospective evaluation of the clinical pulmonary infection score as an early clinical predictor of outcome.
    Luna CM; Blanzaco D; Niederman MS; Matarucco W; Baredes NC; Desmery P; Palizas F; Menga G; Rios F; Apezteguia C
    Crit Care Med; 2003 Mar; 31(3):676-82. PubMed ID: 12626968
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Ventilator-associated pulmonary infection: the germ theory of disease remains viable.
    Solomkin JS
    Microbes Infect; 2005 Feb; 7(2):279-91. PubMed ID: 15777668
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Assessment of patients with poor resolution of HAP].
    Wunderink RG
    Enferm Infecc Microbiol Clin; 2005 Dec; 23 Suppl 3():52-7. PubMed ID: 16854342
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Antibiotic therapy of ventilator-associated pneumonia--a reappraisal of rationale in the era of bacterial resistance.
    Sintchenko V; Iredell JR; Gilbert GL
    Int J Antimicrob Agents; 2001 Sep; 18(3):223-9. PubMed ID: 11673034
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Nosocomial pneumonia in the ICU--year 2000 and beyond.
    Bowton DL
    Chest; 1999 Mar; 115(3 Suppl):28S-33S. PubMed ID: 10084457
    [TBL] [Abstract][Full Text] [Related]  

  • 40. What's new about ventilator-associated pneumonia.
    Kollef MH
    Anesthesiology; 2001 Apr; 94(4):551-3. PubMed ID: 11379671
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.